10x Science
YC W26 ↗San Francisco, US · Founded 2025 · 4 employees · 2 known investors
10x Science provides an AI platform that automates protein characterization for drug developers, reducing months of manual analysis to speed the evaluation of therapeutic candidates in early-stage development.
AI & Machine LearningBiotechEnterprise SoftwareSaaSArtificial IntelligenceB2Bin /10xscience/@10x_Scienceycombinator.com ↗
Founders & leadership· Y Combinator alumni (W26)
Investors · 2
In the news
- 10x Science Raises $4.8M to Apply AI to the Bottleneck Slowing Drug Discoverytheaiinsider.tech · 2026
- 10x Science Raises $4.8M Seed to Transform Molecular Protein Characterization with Explainable AIbiopharmaboardroom.com · 2026
- 10x Science Raises $4.8M Seed to Build AI That Understands Proteins at the Molecular Level - AIwirehpcwire.com · 2026
- 10x Science Raises $4.8M Seed for AI Proteomics - TAMradar Funding Rounds Signalstamradar.com · 2026
- 10x Science Raises $4.8M in Seed Fundingfinsmes.com · 2026
- AI is spitting out more potential drugs than ever. This startup wants to figure out which ones matter. | TechCrunchtechcrunch.com · 2026
- 10x Science: Unlocking the future of drug development 🔑🧬ycombinator.com · 2026